| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $9.1M | +31.5% |
| SG&A Expense | $5.8M | -6.5% |
| Operating Income | -$14.9M | -13.7% |
| Interest Expense | $12K | -20.0% |
| Income Tax | $0 | — |
| Net Income | -$14.4M | -17.4% |
| EPS (Basic) | -$10.19 | -466.1% |
| EPS (Diluted) | -$10.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.8M | -21.0% |
| Current Assets | $10.5M | -21.3% |
| Total Assets | $10.9M | -22.6% |
| Current Liabilities | $3.2M | +25.1% |
| Total Liabilities | $3.4M | +23.7% |
| Stockholders' Equity | $7.5M | -33.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.2M | -9.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $9.6M | -14.3% |
| Free Cash Flow | -$12.2M | -9.5% |
| -466.1% |